Vertex Pharmaceuticals Incorporated (VRTX) Revenue History
Vertex Pharmaceuticals Incorporated (VRTX) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $1.70B |
| 2017-12-31 | $2.49B |
| 2018-12-31 | $3.05B |
| 2019-12-31 | $4.16B |
| 2020-12-31 | $6.21B |
| 2021-12-31 | $7.57B |
| 2022-12-31 | $8.93B |
| 2023-12-31 | $9.87B |
| 2024-12-31 | $11.02B |
| 2025-12-31 | $12.00B |
How VRTX compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc. | $14.34B |
| VTRS | Viatris Inc. | $14.30B |
| HSIC | Henry Schein Inc. | $13.18B |
| BAX | Baxter International Inc. | $11.24B |
| ZTS | Zoetis Inc. Class A | $9.47B |
These are five companies in the same sector as VRTX with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Vertex Pharmaceuticals Incorporated Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("VRTX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | VRTX | $516.44 | -1.77% | 0.86M |
| 3 | ||||
| 4 | ||||
| 5 |